SimpleStart Compounded GLP-1 Weight Loss Program: Nutritional Support Announced

OrderlyMeds has announced its SimpleStart GLP-1 weight loss program, which can be carried out completely online and includes specialized meal plans along with nutritional guidance from licensed dietitians.

-- The recently announced SimpleStart program offers treatment plans for both patients who are new to GLP-1 weight loss programs and individuals who are transferring from a different GLP-1 weight loss program. As part of the campaign, OrderlyMeds is offering both compounded tirzepatide (GLP-1/GIP) and compounded semaglutide (GLP-1); the appropriate treatment will be decided upon a medical evaluation by one of the company’s licensed physicians.

For more information, please visit https://orderlymeds.com/simplestart/

At OrderlyMeds, all treatment begins with a comprehensive evaluation of the patient’s medical history, any past prescriptions, and health goals. Weight loss medications, which include GLP-1 and a combination of GLP-1 and GIP, will be compounded to match the patient’s medical needs - these will work to reduce appetite and cravings, with the ultimate goal of lowering BMI to reduce the risk of developing chronic health conditions like hypertension and heart disease.

The company’s SimpleStart weight loss plan comes with a complimentary onboarding program, which offers participants access to doctor-led webinars, nutritionist support, and personalized workout plans from physicians and health coaches. The program also includes free virtual consults, allowing patients to contact their provider at any time to discuss side effects and other concerns. Additionally, individuals are able to speak to dietitians for science-backed meal plans created specifically for GLP-1 patients.

No additional membership fees, setup costs, or other hidden expenses are required as part of the program.

A patient currently undergoing OrderlyMeds’ weight loss program said, “This is genuinely a miracle drug. I’ve become so much more confident in myself after just 8 months on compounded tirzepatide. I’m also no longer on blood pressure or cholesterol medications. Getting treatment with OrderlyMeds was really a life-changing decision for me.”

To be eligible for the program, the patient must be 18 years or older and have a BMI greater than 25 if they are not already taking a GLP-1 medication; if they are transferring from a different GLP-1 program, they must have a BMI greater than 20. Additionally, the patient cannot be pregnant or breastfeeding, and they must not have a thyroid condition, pancreatic cancer, pancreatitis, MEN2 syndrome, or IBS.

Interested parties can learn more by visiting https://orderlymeds.com/

Contact Info:
Name: Annie Dawson
Email: Send Email
Organization: OrderlyMeds
Address: 235 Ponce De Leon Pl Suite M347, Decatur, Georgia 30030, United States
Website: https://orderlymeds.com/

Source: PressCable

Release ID: 89184356

Should there be any problems, inaccuracies, or doubts arising from the content provided in this press release that require attention or if a press release needs to be taken down, we urge you to notify us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will promptly address your concerns within 8 hours, taking necessary steps to rectify identified issues or assist with the removal process. Providing accurate and dependable information is central to our commitment.

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.64
+2.08 (1.00%)
AAPL  274.23
+2.09 (0.77%)
AMD  210.86
-2.98 (-1.39%)
BAC  51.69
+1.28 (2.54%)
GOOG  313.03
+2.11 (0.68%)
META  653.69
+14.39 (2.25%)
MSFT  400.60
+11.60 (2.98%)
NVDA  195.56
+2.71 (1.41%)
ORCL  147.89
+1.75 (1.20%)
TSLA  417.40
+8.02 (1.96%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.